Clinical trials
Aneurysm trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 4 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 4 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre hospitalier de l'Université de Montréal (CHUM) | 7 |
| University of Alberta | 4 |
| Vascutek Ltd. | 2 |
| Baylor College of Medicine | 1 |
| Cook Research Incorporated | 1 |
| Edge Therapeutics Inc | 1 |
| Hamilton Health Sciences Corporation | 1 |
| Laval University | 1 |
| LuSeed Vascular LTD. | 1 |
| Microvention-Terumo, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aneurysm | 26 |
| Cardiovascular Diseases | 7 |
| Intracranial Aneurysm | 7 |
| Vascular Diseases | 6 |
| Aortic Aneurysm, Abdominal | 3 |
| Arteriovenous Malformations | 3 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 3 |
| Cerebrovascular Disorders | 3 |
| Intracranial Arterial Diseases | 3 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.